File size: 5,943 Bytes
3d1bf3b 8fb54f3 3d1bf3b ef93497 3d1bf3b ef93497 3d1bf3b ef93497 3d1bf3b ef93497 3d1bf3b ef93497 3d1bf3b f9443a2 3d1bf3b 2af1a04 3d1bf3b f9443a2 3d1bf3b ef93497 4c7734e ef93497 3d1bf3b f159fb2 3d1bf3b |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 |
---
language:
- ca
tags:
- biomedical
- clinical
- EHR
- catalan
- drugs
- medications
license: apache-2.0
metrics:
- precision
- recall
- f1
base_model:
- PlanTL-GOB-ES/bsc-bio-ehr-es
model-index:
- name: BSC-NLP4BIA/drug-ner-cat-v1
results:
- task:
type: token-classification
dataset:
name: DrugTEMIST-cat
type: DrugTEMIST-cat
metrics:
- name: precision
type: precision
value: 0.885
- name: recall
type: recall
value: 0.874
- name: f1
type: f1
value: 0.879
- task:
type: token-classification
dataset:
name: CataCCC-drugs
type: CataCCC-drugs
metrics:
- name: precision
type: precision
value: 0.921
- name: recall
type: recall
value: 0.904
- name: f1
type: f1
value: 0.913
widget:
- text: "El diagnóstico definitivo de nuestro paciente fue de un Adenocarcinoma de pulmón cT2a cN3 cM1a Estadio IV (por una única lesión pulmonar contralateral) PD-L1 90%, EGFR negativo, ALK negativo y ROS-1 negativo."
- text: "Durante el ingreso se realiza una TC, observándose un nódulo pulmonar en el LII y una masa renal derecha indeterminada. Se realiza punción biopsia del nódulo pulmonar, con hallazgos altamente sospechosos de carcinoma."
- text: "Trombosis paraneoplásica con sospecha de hepatocarcinoma por imagen, sobre hígado cirrótico, en paciente con índice Child-Pugh B."
---
# DRUG-NER-CAT
## Table of contents
<details>
<summary>Click to expand</summary>
- [Model description](#model-description)
- [How to use](#how-to-use)
- [Limitations and bias](#limitations-and-bias)
- [Training](#training)
- [Evaluation](#evaluation)
- [Additional information](#additional-information)
- [Authors](#authors)
- [Contact information](#contact-information)
- [Licensing information](#licensing-information)
- [Funding](#funding)
- [Citing information](#citing-information)
- [Disclaimer](#disclaimer)
</details>
## Model description
A fine-tuned version of the [bsc-bio-ehr-es](https://huggingface.co/PlanTL-GOB-ES/bsc-bio-ehr-es) model on the [DrugTEMIST](https://zenodo.org/records/11368861) corpus (Catalan Gold Standard Corpus).
For further information, check the [official website](https://temu.bsc.es/multicardioner/).
## How to use
⚠ We recommend pre-tokenizing the input text into words instead of providing it directly to the model, as this is how the model was trained. Otherwise, the results and performance might get affected.
A usage example can be found [here](https://github.com/nlp4bia-bsc/hugging-face-pipeline/blob/main/simple_inference.ipynb).
## Limitations and bias
At the time of submission, no measures have been taken to estimate the bias embedded in the model. However, we are well aware that our models may be biased since the corpora have been collected using crawling techniques on multiple web sources. We intend to conduct research in these areas in the future, and if completed, this model card will be updated.
## Training
The model was trained using the Barcelona Supercomputing Center infrastructure.
## Evaluation
F1 Score: 0.879 on DrugTEMIST (Catalan Gold Standard)
F1 Score: 0.913 on CataCCC-drugs (Catalan Gold Standard)
## Additional information
### Authors
NLP4BIA team at the Barcelona Supercomputing Center ([email protected]).
### Contact information
jan.rodriguez [at] bsc.es
### Licensing information
[Apache License, Version 2.0](https://www.apache.org/licenses/LICENSE-2.0)
### Funding
This research was funded by the Ministerio de Ciencia e Innovación (MICINN) under project AI4ProfHealth (PID2020-119266RA-I00 MICIU/AEI/10.13039/501100011033) and BARITONE (TED2021-129974B-C22). This work is also supported by the European Union’s Horizon Europe Co-ordination \& Support Action under Grant Agreement No 101080430 (AI4HF) as well as Grant Agreement No 101057849 (DataTool4Heartproject).
### Citing information
Please cite the following works:
```
@inproceedings{multicardioner2024overview,
title = {{Overview of MultiCardioNER task at BioASQ 2024 on Medical Speciality and Language Adaptation of Clinical NER Systems for Spanish, English and Italian}},
author = {Salvador Lima-López and Eulàlia Farré-Maduell and Jan Rodríguez-Miret and Miguel Rodríguez-Ortega and Livia Lilli and Jacopo Lenkowicz and Giovanna Ceroni and Jonathan Kossoff and Anoop Shah and Anastasios Nentidis and Anastasia Krithara and Georgios Katsimpras and Georgios Paliouras and Martin Krallinger},
booktitle = {CLEF Working Notes},
year = {2024},
editor = {Faggioli, Guglielmo and Ferro, Nicola and Galuščáková, Petra and García Seco de Herrera, Alba}
}
```
### Disclaimer
The models published in this repository are intended for a generalist purpose and are available to third parties. These models may have bias and/or any other undesirable distortions.
When third parties deploy or provide systems and/or services to other parties using any of these models (or using systems based on these models) or become users of the models, they should note that it is their responsibility to mitigate the risks arising from their use and, in any event, to comply with applicable regulations, including regulations regarding the use of artificial intelligence.
---
Los modelos publicados en este repositorio tienen una finalidad generalista y están a disposición de terceros. Estos modelos pueden tener sesgos y/u otro tipo de distorsiones indeseables.
Cuando terceros desplieguen o proporcionen sistemas y/o servicios a otras partes usando alguno de estos modelos (o utilizando sistemas basados en estos modelos) o se conviertan en usuarios de los modelos, deben tener en cuenta que es su responsabilidad mitigar los riesgos derivados de su uso y, en todo caso, cumplir con la normativa aplicable, incluyendo la normativa en materia de uso de inteligencia artificial. |